YMABY-Mabs Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsAug 8
Mkt Cap$391.22M
Vol760,675.00

About

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
107

Frequently Asked Questions

What is Market Cap of Y-Mabs Therapeutics Inc?
What is the 52-week high for Y-Mabs Therapeutics Inc?
What is the 52-week low for Y-Mabs Therapeutics Inc?
What is Y-Mabs Therapeutics Inc stock price today?
What was Y-Mabs Therapeutics Inc stock price yesterday?
What is the PE ratio of Y-Mabs Therapeutics Inc?
What is the Price-to-Book ratio of Y-Mabs Therapeutics Inc?
What is the 50-day moving average of Y-Mabs Therapeutics Inc?
How many employees does Y-Mabs Therapeutics Inc have?

Advertisement|Remove ads.